SWOT Analysis for Centessa Pharmaceuticals plc - ADR

Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
Company with Low Debt
Stock with Low PE (PE < = 10)
Volume Shockers
Highest Recovery from 52 Week Low

MACD Crossover Below Signal Line
Stocks with Quarter Change % less than Industry
PEG greater than Industry PEG
Stocks in downtrend most likely to cross below SMA-200 soon
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
MACD crossed below zero line previous end of day
MACD crossed below signal line previous end of day
High volume, top losers
Top Losers
Low Piotroski Score : Companies with weak financials
RSI indicating price weakness
Top Losers
Zombies: Companies whose interest payments are higher than revenues
Stocks Underperforming their Industry Price Change in the Quarter

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months